STBT5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 160: | Line 160: | ||
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | |[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | ||
|Disease | |Disease | ||
|Kauser Begum Ravishankar (trainee), with Katie | |||
|2/25/2026 | |||
|5/25/2026 | |||
|PENDING | |||
| | | | ||
| | |Katie Schieffer | ||
| | | | ||
| | | | ||
| Line 182: | Line 182: | ||
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | |[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | ||
|Disease | |Disease | ||
|Karla Sofía Peláez Valdés (trainee); | |||
Katie Schieffer (mentor) | |||
|3/1/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Katie Schieffer | ||
| | | | ||
| | | | ||
| Line 529: | Line 530: | ||
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | |[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | ||
|Disease | |Disease | ||
| | |Katherine Geiersbach | ||
| | |8/11/2023 | ||
| | |11/11/2203 | ||
| | |COMPLETE | ||
| | |1/8/2025 | ||
| | |Katherine Geiersbach | ||
| | |1/8/2025 | ||
| | | | ||
|- | |- | ||
| Line 566: | Line 567: | ||
|3/1/2026 | |3/1/2026 | ||
|6/30/2026 | |6/30/2026 | ||
| | |COMPLETE | ||
| | |3/3/2026 | ||
| | |Katie Schieffer | ||
| | |3/4/2026 | ||
| | | | ||
|- | |- | ||
| Line 1,125: | Line 1,126: | ||
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | |[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,304: | Line 1,305: | ||
|2/20/2022 | |2/20/2022 | ||
|12/9/2025 | |12/9/2025 | ||
| | |COMPLETE | ||
| | |2/26/2026 | ||
|Katie Schieffer | |Katie Schieffer | ||
| | |2/26/2026 | ||
| | | | ||
|- | |- | ||
| Line 1,548: | Line 1,549: | ||
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]] | |[[STBT5:Periosteal_chondroma|Periosteal chondroma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,559: | Line 1,560: | ||
|[[STBT5:Enchondroma|Enchondroma]] | |[[STBT5:Enchondroma|Enchondroma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,570: | Line 1,571: | ||
|[[STBT5:Osteochondroma|Osteochondroma]] | |[[STBT5:Osteochondroma|Osteochondroma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 2,057: | Line 2,058: | ||
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]] | |[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 2,082: | Line 2,083: | ||
|2/23/2026 | |2/23/2026 | ||
|4/12/2026 | |4/12/2026 | ||
| | |COMPLETE | ||
| | |4/27/2026 | ||
| | |Katie Schieffer | ||
| | |4/28/2026 | ||
| | | | ||
|- | |- | ||